251 related articles for article (PubMed ID: 23967318)
1. Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
Takahashi K; Matsumoto Y; Do e Z; Kanazawa M; Satoh K; Shimizu T; Sato A; Fukumoto Y; Shimokawa H
PLoS One; 2013; 8(8):e72558. PubMed ID: 23967318
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
[TBL] [Abstract][Full Text] [Related]
3. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
Wang JA; Chen WA; Wang Y; Zhang S; Bi H; Hong B; Luo Y; Daugherty A; Xie X
Atherosclerosis; 2011 Jul; 217(1):90-6. PubMed ID: 21481872
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
Zhou MS; Tian R; Jaimes EA; Raij L
Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK.
Zhang Y; Naggar JC; Welzig CM; Beasley D; Moulton KS; Park HJ; Galper JB
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1764-71. PubMed ID: 19729613
[TBL] [Abstract][Full Text] [Related]
6. β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice.
Trivedi DB; Loftin CD; Clark J; Myers P; DeGraff LM; Cheng J; Zeldin DC; Langenbach R
Circ Res; 2013 Apr; 112(9):1219-29. PubMed ID: 23524589
[TBL] [Abstract][Full Text] [Related]
7. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
8. Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?
Doyon M; Hale TM; Huot-Marchand JE; Wu R; de Champlain J; DeBlois D
Vascul Pharmacol; 2011; 54(1-2):5-12. PubMed ID: 20951229
[TBL] [Abstract][Full Text] [Related]
9. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
[TBL] [Abstract][Full Text] [Related]
10. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.
Stegbauer J; Thatcher SE; Yang G; Bottermann K; Rump LC; Daugherty A; Cassis LA
J Vasc Surg; 2019 Nov; 70(5):1658-1668.e1. PubMed ID: 30850299
[TBL] [Abstract][Full Text] [Related]
11. Focal histopathological progression of porcine experimental abdominal aortic aneurysm is mitigated by atorvastatin.
Houdek K; Moláček J; Třeška V; Křížková V; Eberlová L; Boudová L; Nedorost L; Tolinger P; Kočová J; Kobr J; Baxa J; Liška V; Witter K; Tonar Z
Int Angiol; 2013 Jun; 32(3):291-306. PubMed ID: 23711681
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice.
Choke E; Cockerill GW; Dawson J; Howe F; Wilson WR; Loftus IM; Thompson MM
J Vasc Surg; 2010 Jul; 52(1):159-166.e1. PubMed ID: 20471768
[TBL] [Abstract][Full Text] [Related]
14. Licochalcone A attenuates abdominal aortic aneurysm induced by angiotensin II via regulating the miR-181b/SIRT1/HO-1 signaling.
Hou X; Yang S; Zheng Y
J Cell Physiol; 2019 May; 234(5):7560-7568. PubMed ID: 30417353
[TBL] [Abstract][Full Text] [Related]
15. Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms.
Zhang X; Thatcher S; Wu C; Daugherty A; Cassis LA
J Vasc Surg; 2015 Mar; 61(3):767-76. PubMed ID: 24439319
[TBL] [Abstract][Full Text] [Related]
16. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
17. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
[TBL] [Abstract][Full Text] [Related]
18. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3.
Qin Z; Bagley J; Sukhova G; Baur WE; Park HJ; Beasley D; Libby P; Zhang Y; Galper JB
J Mol Cell Cardiol; 2015 Oct; 87():160-70. PubMed ID: 26299839
[TBL] [Abstract][Full Text] [Related]
20. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
